Method for thrombogenicity testing of implanted medical device
US-9193987-B2 · Nov 24, 2015 · US
US9951372B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9951372-B2 |
| Application number | US-201314032420-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 20, 2013 |
| Priority date | Sep 2, 2011 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides compounds and methods for assaying redox state of metabolically active cells and methods for assaying enzyme activity and/or metabolite level by coupling to redox defining co-factor NAD(P)/NAD(P)H measurement.
Opening claim text (preview).
The invention claimed is: 1. A method for detecting cellular metabolites in a sample comprising, a. contacting the sample with a compound of formula (II), (III), or (IV), a dehydrogenase amplification enzyme system, NAD or NADP, a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate, and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 2. The method of claim 1 , wherein the compound, dehydrogenase amplification enzyme, diaphorase, NAD or NADP and luciferase reaction mixture are in a single composition. 3. A method of detecting NADH or NADPH in a sample comprising: a. contacting the sample with a compound of formula (II), (III), or (IV), a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 4. The method of claim 3 , wherein the sample is further contacted with a diaphorase inhibitor. 5. The method of claim 3 , wherein the compound, diaphorase and luciferase reaction mixture are in a single composition. 6. A method of determining total NAD(P)/NAD(P)H in a sample comprising: a. contacting the sample with a dehydrogenase amplification enzyme system, a compound of formula (II), (III) or (IV), a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate, and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 7. The method of claim 6 , wh
with fluorescent label · CPC title
involving dehydrogenase · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Ortho-condensed systems · CPC title
co-enzymes or co-factors, e.g. NAD or ATP · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.